Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HUMANA INC Director's Dealing 2024

Feb 23, 2024

30145_dirs_2024-02-23_e8ea1c90-3ba8-4788-ac06-2f45a2f3a303.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2024-02-21

Reporting Person: Diamond Susan M (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-22 Humana Common M 3356 Acquired 7436 Direct
2024-02-22 Humana Common F 1125 $366.105 Disposed 6311 Direct
2024-02-21 Humana Common A 13480 Acquired 19791 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-21 Options $367.21 A 9989 Acquired 2031-02-21 Humana Common (9989) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Humana Common 2182 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options $376.61 2028-02-22 Humana Common (1508) 1508 Direct
Options $428.6767 2028-08-01 Humana Common (3793) 3793 Direct
Options $425.055 2029-02-21 Humana Common (5562) 5562 Direct
Options $510.2425 2030-02-24 Humana Common (6810) 6810 Direct
Restricted Stock Units $ Humana Common (311) 311 Direct
Restricted Stock Units $ Humana Common (512) 512 Direct
Restricted Stock Units $ Humana Common (1176) 1176 Direct
Phantom Stock Units $ Humana Common (325) 325 Indirect

Footnotes

F1: Shares held for the benefit of the reporting person as of January 31, 2024 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).

F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.

F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 8/1/2021, vesting in three annual increments from 8/1/22 to 8/1/24.

F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.

F5: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.

F6: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

F7: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8: Restricted stock units granted to reporting person on 08/1/2021, 33% of the award is vesting on 8/1/22, 8/1/23, and 8/1/24.

F9: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

F10: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

F11: Restricted stock units granted to reporting person on 2/21/24.

F12: Includes 13,480 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F13: Phantom Stock Units held for the benefit of reporting person as of January 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F14: Includes Performance Stock Units not required to be reported until vest.

F15: Shares disposed of represent payment of tax liability resulting from vesting of Performance Stock Units on 2/22/24.